Ling‐Hua Meng

6.5k citations
15 papers · 427 indexed · h-index 10
Topics
DNA Repair Mechanisms (5 papers)Cancer therapeutics and mechanisms (5 papers)Bioactive Compounds and Antitumor Agents (2 papers)
Partner nations
United StatesChinaNorway

In The Last Decade

Ling‐Hua Meng

15 papers receiving 420 citations

Peers

Ling‐Hua Meng
Comparison fields: 5 of 75
  • Molecular Biology 323
  • Oncology 128
  • Cancer Research 55
  • Organic Chemistry 46
  • Pharmacology 29
Replace Michael V. Fiandalo with:
Michael V. Fiandalo United States
Young Ju Yoon South Korea
Prabodh K. Kandala United States
Shao‐Hsing Weng Taiwan
Junjie Lan China
Yulia Aleksandrova Russia
Sudhakar Manda India
C. Gaggini Italy
Alain Pierré France
José D. Solano Mexico
Ling‐Hua Meng relative to Michael V. Fiandalo United States Michael V. Fiandalo's profile →
Citations per field
00.5×1.5×1.8×
Michael V. Fiandalo · 1×
Citations per year

Countries citing papers authored by Ling‐Hua Meng

Since Specialization
Citations

This map shows the geographic impact of Ling‐Hua Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling‐Hua Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling‐Hua Meng more than expected).

Fields of papers citing papers by Ling‐Hua Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling‐Hua Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling‐Hua Meng. The network helps show where Ling‐Hua Meng may publish in the future.

Co-authorship network of co-authors of Ling‐Hua Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Ling‐Hua Meng. A scholar is included among the top collaborators of Ling‐Hua Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling‐Hua Meng. Ling‐Hua Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 1
2 7
3 16
4 2
5 4
6 21
7 9
8 14
9 12
10 50
11 33
12 96
13 38
14 82
15 42

About Ling‐Hua Meng

Ling‐Hua Meng is a scholar working on Toxicology, Molecular Biology and Oncology, having authored 15 papers that have together received 427 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (5 papers), Cancer therapeutics and mechanisms (5 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Toxicology (22 citations), Molecular Biology (323 citations) and Oncology (128 citations). Ling‐Hua Meng has collaborated with scholars based in United States, China and Norway. Frequent co-authors include Yves Pommier, V. Ashutosh Rao, Ze‐Hong Miao, Haruyuki Takemura, Smitha Antony, Phillip North, Takahisa Furuta, Hongliang Zhang, Glenda Kohlhagen and Edward A. Sausville. Their work appears in journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026